25
Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia By Alex Sheng

Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

  • Upload
    marci

  • View
    48

  • Download
    7

Embed Size (px)

DESCRIPTION

Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia. By Alex Sheng. What is Retinoic Acid?. The most biologically active retinoid Derived from Vitamin A. What Does Retinoic Acid Do in the Organism?. Effect of RA on the hindbrain Normal CNS - PowerPoint PPT Presentation

Citation preview

Page 1: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic

Leukemia

By Alex Sheng

Page 2: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

What is Retinoic Acid?

The most biologically active retinoid

Derived from Vitamin A

Page 3: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

What Does Retinoic Acid Do in the Organism? Regulates neuronal

differentiation. Patterns the

anteroposterior (AP) axes.

Upregulates prepattern and neurogenic genes

Downregulates genes that inhibit neurogenesis.

Effect of RA on the hindbrain

a) Normal CNS

b) Excess RA – missing anterior hindbrain

c) Lower RA – rhombomere changes

Page 4: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

What Does Retinoic Acid Do in the Organism? RA controls the number of primary neurons. In humans, RA also regulates myeloid cell

proliferation and differentiation.

Primary neurons at the neurula stage.

Page 5: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

RA’s Role in Neurogenesis

Page 6: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

The Teratogenic Effect of Retinoic Acid

•Retinoic acid is teratogenic in humans at very low doses.

•Exposure to RA between 3-5 weeks of pregnancy may result in malformations of the fetus

Page 7: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Retinoid Acid Receptor α Member of the nuclear

hormone receptor superfamily that also includes the retinoid X receptor (RXR).

Found in the nucleus of hematopoietic cells.

Page 8: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

The Normal Function of RAR in the Cell Receptor for all-trans retinoic acid (ATRA) and 9-cis RA. Active in cellular differentiation and morphogenesis. Important for hematopoietic cells differentiation and

maturation. It acts as a tumor suppressor.

Page 9: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

The Normal Function of RAR in the Cell In the absence of RA, the RAR/RXR heterodimer recruits

a repression complex that causes the deacetylation of core histones resulting in chromatin condensation and transcriptional repression.

Page 10: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

The Normal Function of RAR in the Cell In the presence of RA, the repression complex dissociates,

promoting the association of coactivator complex that leads to acetylation of core histones, resulting in chromatin relaxation, promotor clearance and transcription activation.

Page 11: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

RAR Knockouts

Mice selectively deficient in the RAR-alpha 1 isoform appear normal with no discernible disorder in hematopoiesis.

Knockout mice in which both isoforms of RAR have been disrupted display early post natal lethality and testis degeneration, but do not display any overt abnormality in hematopoiesis

Page 12: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

RAR Knockouts

There are two isoforms of RAR-alpha (RAR-alpha 1 and RAR-alpha 2)

There is genetic redundancy in the RAR-alpha gene.

Page 13: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia (APL) A common form of acute

myeloid leukemia (AML) Involves the accumulation

of immature promyelocytes in patient bone marrow and peripheral blood.

Page 14: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia (APL) ~50 children diagnosed each year. Represents about one percent of childhood

leukemia. Found more often in children between the

ages of two and three, and in adults over 40 More frequently in children of Hispanic and

Mediterranean origin.

Page 15: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Symptoms of Acute Promyelocytic Leukemia (APL) Fatigue Weakness Shortness of breath

(from anemia) Easy bruising and

bleeding Fever and infection

(from lack of normal white blood cells)

Page 16: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Acute Promyelocytic Leukemia (APL) Often caused by a

chromosomal translocation involving the RARα gene on chromosome 17.

Page 17: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Fusion Partners of Mutant RARα promyelocyte gene (PML) promyelocytic leukemia zinc finger gene

(PLZF) The mutant RARα form fusion proteins PML-

RARα and PLZF- RARα.

Page 18: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Fusion Proteins PML- RARα and PLZF- RARα

The PML/RARa fusion protein blocks the differentiation of promyelocytes to granulocytes.

Page 19: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

What Goes Wrong in APL? PML/RAR alpha fusion protein recruits multiple

nuclear co-repressor complex to RAR promoters This leads to transcriptional repression and

promyelocytic differentiation blockage.

Page 20: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Treatments for APL Pharmacological concentrations of RA trigger

dissociation of corepressor complexes from PML- RARα but not PLZF- RARα

Also allows for association of coactivator complexes.

Leads to activation of gene expression, leukemia cell differentiation and clinical remission.

Page 21: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia
Page 22: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Treatment Success Standard frontline therapy for APL has been

high doses of all trans RA (ATRA) in combination with chemotherapy.

The treatment results in clinical remission in approximately 90% of patients.

Page 23: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Treatments for APL

Treatment of ATRA does not kill the undifferentiated promyelocytes. Instead, it allows them to grow and mature normally, to differentiate and to apoptose.

Page 24: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Sources http://en.wikipedia.org/wiki/Acute_promyelocytic_leukemia Maden, Malcolm. “Retinoid Signaling in the Development of the

Central Nervous System." Nature Reviews - Neuroscience 3 (2002): 843-853.

Lin, Richard J et al. “Transcriptional regulation in acute promyelocytic leukemia.” Oncogene (2001) 20, 7204-7215.

Lufkin T. et al. “High postnatal lethality and testis degeneration in retinoic acid receptor alpha mutant mice.” Proc Natl Acad Sci U S A. 1993 Aug 1;90(15):7225-9.

Stainier, D.Y.R. and Fishman, M.C. (1992) Patterning the zebrafish heart tube: acquisition of anteroposterior polarity. Dev. Biol. 153: 91-10

Page 25: Retinoic Acid Receptor-Alpha and Its Role in Acute Promyelocytic Leukemia

Make cue cards Get rid of details and put on cue cards More pictures – use a mac Single knockout Transcription factor Make a picture for